DRMA
Price
$5.79
Change
+$0.06 (+1.05%)
Updated
Sep 2, 03:20 PM (EDT)
Capitalization
3.91M
PVLA
Price
$52.72
Change
-$1.43 (-2.64%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
598.88M
Interact to see
Advertisement

DRMA vs PVLA

Header iconDRMA vs PVLA Comparison
Open Charts DRMA vs PVLABanner chart's image
Dermata Therapeutics
Price$5.79
Change+$0.06 (+1.05%)
Volume$500
Capitalization3.91M
Palvella Therapeutics
Price$52.72
Change-$1.43 (-2.64%)
Volume$800
Capitalization598.88M
DRMA vs PVLA Comparison Chart in %
Loading...
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRMA vs. PVLA commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRMA is a Hold and PVLA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (DRMA: $5.74 vs. PVLA: $54.15)
Brand notoriety: DRMA and PVLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRMA: 122% vs. PVLA: 39%
Market capitalization -- DRMA: $3.91M vs. PVLA: $598.88M
DRMA [@Biotechnology] is valued at $3.91M. PVLA’s [@Biotechnology] market capitalization is $598.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRMA’s FA Score shows that 1 FA rating(s) are green whilePVLA’s FA Score has 1 green FA rating(s).

  • DRMA’s FA Score: 1 green, 4 red.
  • PVLA’s FA Score: 1 green, 4 red.
According to our system of comparison, PVLA is a better buy in the long-term than DRMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRMA’s TA Score shows that 3 TA indicator(s) are bullish while PVLA’s TA Score has 3 bullish TA indicator(s).

  • DRMA’s TA Score: 3 bullish, 5 bearish.
  • PVLA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PVLA is a better buy in the short-term than DRMA.

Price Growth

DRMA (@Biotechnology) experienced а +4.74% price change this week, while PVLA (@Biotechnology) price change was +1.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.59%. For the same industry, the average monthly price growth was +22.14%, and the average quarterly price growth was +32.80%.

Industries' Descriptions

@Biotechnology (+6.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PVLA($599M) has a higher market cap than DRMA($3.91M). PVLA has higher P/E ratio than DRMA: PVLA (11.98) vs DRMA (0.27). PVLA YTD gains are higher at: 351.250 vs. DRMA (-57.482). DRMA has higher annual earnings (EBITDA): -10.54M vs. PVLA (-23.27M). PVLA has more cash in the bank: 70.4M vs. DRMA (6.48M). DRMA (0) and PVLA (0) have equivalent revenues.
DRMAPVLADRMA / PVLA
Capitalization3.91M599M1%
EBITDA-10.54M-23.27M45%
Gain YTD-57.482351.250-16%
P/E Ratio0.2711.982%
Revenue00-
Total Cash6.48M70.4M9%
Total Debt175KN/A-
FUNDAMENTALS RATINGS
PVLA: Fundamental Ratings
PVLA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRMAPVLA
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
79%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
DRMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PVLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHIX23.020.08
+0.35%
Saratoga Health & Biotechnology I
TCVYX24.20-0.04
-0.17%
Touchstone Mid Cap Value Y
LAFRX20.37-0.05
-0.24%
Lord Abbett Affiliated R3
VYSVX21.75-0.07
-0.32%
Vericimetry US Small Cap Value
GABIX50.53-0.20
-0.39%
Gabelli Asset I

DRMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRMA has been loosely correlated with PVLA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if DRMA jumps, then PVLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRMA
1D Price
Change %
DRMA100%
+7.29%
PVLA - DRMA
40%
Loosely correlated
+5.56%
NUVL - DRMA
30%
Poorly correlated
+0.74%
KRRO - DRMA
28%
Poorly correlated
-2.49%
ATHA - DRMA
25%
Poorly correlated
-1.74%
ASND - DRMA
25%
Poorly correlated
+0.19%
More

PVLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PVLA has been loosely correlated with MLEC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PVLA jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PVLA
1D Price
Change %
PVLA100%
+5.56%
MLEC - PVLA
53%
Loosely correlated
-0.69%
DRMA - PVLA
42%
Loosely correlated
+7.29%
OCUL - PVLA
35%
Loosely correlated
-2.48%
ERAS - PVLA
34%
Loosely correlated
N/A
OBIO - PVLA
34%
Loosely correlated
+0.74%
More